Diagnostic pathology has long been the cornerstone of medical diagnosis and prognosis. Traditionally, pathologists relied on microscopic examination of tissue samples to identify diseases. However, the landscape of diagnostic pathology has undergone a profound transformation with the advent of molecular biomarkers. These biomarkers, which include genetic mutations, proteins and other molecular signatures, have revolutionized the way diseases are diagnosed, classified and treated. The primary goal of diagnostic pathology is to provide accurate and timely diagnoses to help clinicians manage patients effectively. By studying the cellular and molecular characteristics of tissues, pathologists can identify the presence of abnormal changes indicative of disease. These findings are often reported in pathology reports, which serve as essential tools for clinicians in formulating treatment plans and monitoring patient progress.
HTML PDFShare this article
Molecular Biomarkers & Diagnosis received 2054 citations as per Google Scholar report
